{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:53Z","timestamp":1791270173660,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T00:00:00Z","timestamp":1474243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12017-016-8439-1","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T08:23:53Z","timestamp":1474273433000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer\u2019s Disease and Other Neurodegenerative Disorders"],"prefix":"10.1007","volume":"19","author":[{"given":"Pashtun","family":"Shahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Christer","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,19]]},"reference":[{"issue":"9533","key":"8439_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow, K., de Leon, M. J., & Zetterberg, H. (2006). Alzheimer\u2019s disease. Lancet, 368(9533), 387\u2013403.","journal-title":"Lancet"},{"issue":"3","key":"8439_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology, 6(3), 131\u2013144.","journal-title":"Nature Reviews Neurology"},{"key":"8439_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnins.2015.00345","volume":"9","author":"K Blennow","year":"2015","unstructured":"Blennow, K., & Zetterberg, H. (2015). The past and the future of Alzheimer\u2019s disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events. Frontiers in Neuroscience, 9, 345.","journal-title":"Frontiers in Neuroscience"},{"issue":"8","key":"8439_CR4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2007.10.018","volume":"30","author":"F Bostrom","year":"2009","unstructured":"Bostrom, F., Hansson, O., Gerhardsson, L., Lundh, T., Minthon, L., Stomrud, E., et al. (2009). CSF Mg and Ca as diagnostic markers for dementia with lewy bodies. Neurobiology of Aging, 30(8), 1265\u20131271.","journal-title":"Neurobiology of Aging"},{"issue":"Pt 11","key":"8439_CR5","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., et al. (2006). CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease. Brain a Journal of Neurology, 129(Pt 11), 3035\u20133041.","journal-title":"Brain a Journal of Neurology"},{"key":"8439_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.10.062","volume":"229","author":"A Durukan Tolvanen","year":"2013","unstructured":"Durukan Tolvanen, A., Westberg, J. A., Serlachius, M., Chang, A. C., Reddel, R. R., Andersson, L. C., et al. (2013). Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance. Neuroscience, 229, 49\u201354.","journal-title":"Neuroscience"},{"issue":"9503","key":"8439_CR7","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: A Delphi consensus study. Lancet, 366(9503), 2112\u20132117.","journal-title":"Lancet"},{"issue":"3","key":"8439_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology, 5(3), 228\u2013234.","journal-title":"Lancet Neurology"},{"issue":"3","key":"8439_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-101878","volume":"24","author":"P Johansson","year":"2011","unstructured":"Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J. O., Andreasson, U., et al. (2011). Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: diagnostic performance in a homogeneous mono-center population. Journal of Alzheimer\u2019s Disease JAD, 24(3), 537\u2013546.","journal-title":"Journal of Alzheimer\u2019s Disease JAD"},{"key":"8439_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","volume":"568","author":"ZS Khachaturian","year":"1989","unstructured":"Khachaturian, Z. S. (1989). Calcium, membranes, aging, and Alzheimer\u2019s disease. Introduction and overview. Annals of the New York Academy of Sciences, 568, 1\u20134.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"8439_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb44398.x","volume":"747","author":"ZS Khachaturian","year":"1994","unstructured":"Khachaturian, Z. S. (1994). Calcium hypothesis of Alzheimer\u2019s disease and brain aging. Annals of the New York Academy of Sciences, 747, 1\u201311.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"8439_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0733-8619(05)70204-8","volume":"18","author":"PJ Lindsberg","year":"2000","unstructured":"Lindsberg, P. J., Roine, R. O., Tatlisumak, T., Sairanen, T., & Kaste, M. (2000). The future of stroke treatment. Neurologic Clinics, 18(2), 495\u2013510.","journal-title":"Neurologic Clinics"},{"issue":"12","key":"8439_CR13","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America, 82(12), 4245\u20134249.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"8439_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson, B., Lautner, R., Andreasson, U., Ohrfelt, A., Portelius, E., Bjerke, M., et al. (2016). CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis. Lancet Neurology, 15(7), 673\u2013684.","journal-title":"Lancet Neurology"},{"issue":"12","key":"8439_CR15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","volume":"67","author":"C Reitz","year":"2010","unstructured":"Reitz, C., Tang, M. X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010). Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Archives of Neurology, 67(12), 1491\u20131497.","journal-title":"Archives of Neurology"},{"issue":"10","key":"8439_CR16","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.peptides.2004.03.031","volume":"25","author":"M Serlachius","year":"2004","unstructured":"Serlachius, M., Zhang, K. Z., & Andersson, L. C. (2004). Stanniocalcin in terminally differentiated mammalian cells. Peptides, 25(10), 1657\u20131662.","journal-title":"Peptides"},{"issue":"1","key":"8439_CR17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","volume":"126","author":"DL Sparks","year":"1994","unstructured":"Sparks, D. L., Scheff, S. W., Hunsaker, J. C., 3rd, Liu, H., Landers, T., & Gross, D. R. (1994). Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Experimental Neurology, 126(1), 88\u201394.","journal-title":"Experimental Neurology"},{"issue":"4","key":"8439_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0197-4580(91)90001-Z","volume":"12","author":"MN Subhash","year":"1991","unstructured":"Subhash, M. N., Padmashree, T. S., Srinivas, K. N., Subbakrishna, D. K., & Shankar, S. K. (1991). Calcium and phosphorus levels in serum and CSF in dementia. Neurobiology of Aging, 12(4), 267\u2013269.","journal-title":"Neurobiology of Aging"},{"issue":"3","key":"8439_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0016-6480(86)90149-8","volume":"63","author":"GF Wagner","year":"1986","unstructured":"Wagner, G. F., Hampong, M., Park, C. M., & Copp, D. H. (1986). Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. General and Comparative Endocrinology, 63(3), 481\u2013491.","journal-title":"General and Comparative Endocrinology"},{"issue":"2","key":"8439_CR20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mce.2011.11.007","volume":"349","author":"BH Yeung","year":"2012","unstructured":"Yeung, B. H., Law, A. Y., & Wong, C. K. (2012). Evolution and roles of stanniocalcin. Molecular and Cellular Endocrinology, 349(2), 272\u2013280.","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"10","key":"8439_CR21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.peptides.2004.04.015","volume":"25","author":"Y Yoshiko","year":"2004","unstructured":"Yoshiko, Y., & Aubin, J. E. (2004). Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides, 25(10), 1663\u20131669.","journal-title":"Peptides"},{"issue":"7","key":"8439_CR22","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1073\/pnas.97.7.3637","volume":"97","author":"K Zhang","year":"2000","unstructured":"Zhang, K., Lindsberg, P. J., Tatlisumak, T., Kaste, M., Olsen, H. S., & Andersson, L. C. (2000). Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America, 97(7), 3637\u20133642.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"8439_CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)65587-3","volume":"153","author":"KZ Zhang","year":"1998","unstructured":"Zhang, K. Z., Westberg, J. A., Paetau, A., von Boguslawsky, K., Lindsberg, P., Erlander, M., et al. (1998). High expression of stanniocalcin in differentiated brain neurons. The American Journal of Pathology, 153(2), 439\u2013445.","journal-title":"The American Journal of Pathology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-016-8439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-016-8439-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-016-8439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T14:54:20Z","timestamp":1568386460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-016-8439-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,19]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["8439"],"URL":"https:\/\/doi.org\/10.1007\/s12017-016-8439-1","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,19]]}}}